English
简体中文
Total: £ 56.28
2026-03-25 | Pages: 116 | Tables: 115
The global Microbiome Modulator market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Microbiome Modulator is projected to increase from US$ million in ...
2026-03-25 | Pages: 105 | Tables: 107
The global Invasive Fungal Disease (IFD) Drugs market was valued at US$ 2806 million in 2025 and is anticipated to reach US$ 3728 million by 2032, at a CAGR of 4.2% from 2026 to 2032.Invasive Fungal Disease (IFD) refers to an infectious disease in wh...
2026-03-25 | Pages: 155 | Tables: 157
The global Clinical Trials Comparator And Co-Medication Sourcing market was valued at US$ 1726 million in 2025 and is anticipated to reach US$ 2289 million by 2032, at a CAGR of 4.2% from 2026 to 2032.Clinical Trials Comparator And Co-Medication Sour...
2026-03-25 | Pages: 146 | Tables: 146
The global Clinical Trial Drug Sourcing market was valued at US$ 2030 million in 2025 and is anticipated to reach US$ 2697 million by 2032, at a CAGR of 4.2% from 2026 to 2032.Clinical Trial Drug Sourcing refers to the specialized services provided b...
2026-03-25 | Pages: 111 | Tables: 117
The global Herbal Supplements and Medicine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Herbal supplements are products derived from plants, including their oils, roots, lea...
2026-03-24 | Pages: 104 | Tables: 102
The global Fully Automatic Cell Culture System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Fully Automatic Cell Culture System is projected to...
2026-03-24 | Pages: 130 | Tables: 125
The global Drugstore Chain Retail Solutions market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Drugstore Chain Retail Solutions is projected to incre...
2026-03-24 | Pages: 96 | Tables: 96
The global Severe Eosinophilic Asthma Treatment market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Severe Eosinophilic Asthma Treatment is projected ...
2026-03-24 | Pages: 140 | Tables: 133
The global Small Scale Plasma Fractionation market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Small Scale Plasma Fractionation is projected to incre...
2026-03-24 | Pages: 176 | Tables: 166
The global Lung Cancer Robotic Radiotherapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Lung Cancer Robotic Radiotherapy is projected to incre...
2026-03-24 | Pages: 156 | Tables: 147
The global Low-Density Lipoprotein (LDL) Cholesterol Test market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Low-Density Lipoprotein (LDL) Cholestero...
2026-03-24 | Pages: 143 | Tables: 149
The global Regular Health Screening Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Regular Health Screening Services is projected to inc...
2026-03-24 | Pages: 134 | Tables: 122
The global Large Scale Plasma Separation market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Large Scale Plasma Separation is projected to increase fr...
2026-03-24 | Pages: 111 | Tables: 118
The global Donor Transfusion Diagnosis market was valued at US$ 2300 million in 2025 and is anticipated to reach US$ 4178 million by 2032, at a CAGR of 8.9% from 2026 to 2032.The gross profit margin of major companies in the industry is between 40%–6...
2026-03-24 | Pages: 154 | Tables: 143
The global Lung Biopsy Systems market was valued at US$ 5720 million in 2025 and is anticipated to reach US$ 10879 million by 2032, at a CAGR of 13.7% from 2026 to 2032.Lung Biopsy Systems refer to a set of diagnostic equipment used to safely obtain ...
